HL7 Austria ELGA Laboratory Report R4 Implementation Guide
0.1.0 - ci-build
HL7 Austria ELGA Laboratory Report R4 Implementation Guide, published by HL7 Austria. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/gabriel0316/test-laboratory/ and changes regularly. See the Directory of published versions
| Official URL: https://fhir.hl7.at/elga-labor/ValueSet/at-lab-result-interpretation-vs | Version: 0.1.0 | |||
| Draft as of 2026-05-04 | Computable Name: ATLabResultInterpretationVS | |||
Value set for laboratory result interpretations used in Austrian ELGA Laboratory Reports. Aligned with the HL7 ObservationInterpretation code system.
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation version 📍4.0.0| Code | Display | Definition |
| N | Normal | The result or observation value is within the reference range or expected norm (as defined for the respective test procedure). \[Note: Applies to numeric or non-numeric results.\] |
| L | Low | The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure). Synonym: Below low normal |
| H | High | The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure). Synonym: Above high normal |
| LL | Critical low | The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Below lower panic limits. |
| HH | Critical high | The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Above upper panic limits. |
| A | Abnormal | The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure). \[Note: Typically applies to non-numeric results.\] |
| AA | Critical abnormal | The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure). \[Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.\] |
| R | Resistant | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\] \[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
| S | Susceptible | Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\] \[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
| I | Intermediate | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\] \[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\] \[Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\] \[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
| POS | Positive | A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. |
| NEG | Negative | An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. \[Note: Negative does not necessarily imply the complete absence of the specified item.\] |
| IND | Indeterminate | The specified component / analyte, organism or clinical sign could neither be declared positive / negative nor detected / not detected by the performed test or procedure. *Usage Note:* For example, if the specimen was degraded, poorly processed, or was missing the required anatomic structures, then "indeterminate" (i.e. "cannot be determined") is the appropriate response, not "equivocal". |
| E | Equivocal | The test or procedure was successfully performed, but the results are borderline and can neither be declared positive / negative nor detected / not detected according to the current established criteria. |
| D | Significant change down | The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
| U | Significant change up | The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
Expansion performed internally based on codesystem ObservationInterpretation v4.0.0 (CodeSystem)
This value set contains 16 concepts
| System | Code | Display (de) | Definition | JSON | XML |
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | N | Normal | The result or observation value is within the reference range or expected norm (as defined for the respective test procedure). [Note: Applies to numeric or non-numeric results.] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | L | Low | The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure). Synonym: Below low normal | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | H | High | The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure). Synonym: Above high normal | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | LL | Critical low | The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Below lower panic limits. | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | HH | Critical high | The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Above upper panic limits. | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | A | Abnormal | The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure). [Note: Typically applies to non-numeric results.] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | AA | Critical abnormal | The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure). [Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | R | Resistant | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 [Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.] [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | S | Susceptible | Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2 [Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.] [Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | I | Intermediate | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 [Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.] [Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.] [Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.] [Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | POS | Positive | A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | NEG | Negative | An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure. [Note: Negative does not necessarily imply the complete absence of the specified item.] | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | IND | Indeterminate | The specified component / analyte, organism or clinical sign could neither be declared positive / negative nor detected / not detected by the performed test or procedure. Usage Note: For example, if the specimen was degraded, poorly processed, or was missing the required anatomic structures, then "indeterminate" (i.e. "cannot be determined") is the appropriate response, not "equivocal". | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | E | Equivocal | The test or procedure was successfully performed, but the results are borderline and can neither be declared positive / negative nor detected / not detected according to the current established criteria. | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | D | Significant change down | The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). | ||
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation | U | Significant change up | The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |